Related Experiment Video
Updated: Sep 12, 2026
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Identification of key genes affecting disease free survival time of pediatric acute lymphoblastic leukemia based on
Hai-Yan Gao1, Xin-Guo Luo2, Xi Chen1
1Department of Hematology, The Second Affiliated Hospital in Harbin Medical University, Harbin 150086, China.
Insights
Identifying key genes in pediatric acute lymphoblastic leukemia (ALL) is crucial for improving patient outcomes. This study highlights HK3 and PTGS2 as potential therapeutic targets, offering new hope for treating pediatric ALL.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Pediatric acute lymphoblastic leukemia (ALL) has a poor prognosis, suggesting critical genes influence outcomes.
- Identifying these genes is essential for developing targeted therapies and improving survival rates.
Purpose of the Study:
- To identify key genes and pathways associated with pediatric ALL prognosis.
- To explore potential therapeutic targets for pediatric ALL based on gene expression and pathway analysis.
Main Methods:
- Differential gene expression analysis using the limma package in R.
- Prognostic gene identification using Survival and KMsurv packages in R.
- Latent pathway identification analysis (LPIA) and network construction using Cytoscape.
Main Results:
- Screened 2796 differentially expressed genes (DEGs) and 353 prognosis genes from 8284 genes.
- Identified 75 key genes, enriched in 25 Gene Ontology (GO) functions and the chronic myeloid leukemia pathway.
- Highlighted HK3 and PTGS2 as crucial genes involved in glycolysis and arachidonic acid metabolism, potentially impacting pediatric ALL prognosis.
Conclusions:
- HK3 and PTGS2 are identified as significant key genes potentially playing vital roles in pediatric ALL.
- These genes, through specific metabolic pathways, represent promising therapeutic targets for intervention in pediatric ALL.
Abstract:
The poor prognosis of pediatric acute lymphoblastic leukemia (ALL) indicates the existence of key candidate genes that affect pediatric ALL and its prognosis. The limma package in R was applied to screen differentially expressed genes (DEGs), and the Survival package and KMsurv package in R were used to screen disease free survival time related genes (prognosis genes). Then, based on latent pathway identification analysis (LPIA), latent pathways were identified, and pathway-pathway interaction network was constructed and visualized by Cytoscape. Based on the expression values of 8284 genes in 126 chips, 2796 DEGs and 353 prognosis genes were screened out. After overlapping DEGs and prognosis genes, 75 key genes were identified, which were most significantly enriched in 25 GO functions and chronic myeloid leukemia pathway. For the 75 key genes, 27 disease risk sub-pathways were identified, and HK3, HNMT, SULT2B1, KYNU, and PTGS2 were the significant key genes which were enriched in these sub-pathways. Furthermore, based on pathway-pathway interaction analysis, HK3 and PTGS2 were predicted as the most important genes. Through glycolysis and arachidonic acid metabolism, HK3 and PTGS2 might play important roles in pediatric ALL and its prognosis, and thus, might be potential targets for therapeutic intervention to suppress pediatric ALL.
